Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0554 USD | +0,73% | +1,84% | +49,73% |
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 8,59 mln. 8,03 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -17 mln. -15,9 mln. | Nettowinst (verlies) 2022 | -19 mln. -17,77 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 23,78 mln. 22,24 mln. | Nettoliquiditeiten 2022 | 6,72 mln. 6,29 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-1,66
x | K/w-verhouding 2022 |
-0,43
x | Werknemers | 18 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 84,97% |
Recentste transcriptie over Bellerophon Therapeutics, Inc.
1 dag | +0,73% | ||
1 week | +1,84% | ||
Lopende maand | -2,46% | ||
1 maand | -3,99% | ||
3 maanden | -9,18% | ||
6 maanden | -5,62% | ||
Lopend jaar | +49,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 29-01-15 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 29-06-15 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,0554 | +0,73% | 17 511 |
25-04-24 | 0,055 | +1,66% | 10 136 |
24-04-24 | 0,0541 | -7,68% | 47 040 |
23-04-24 | 0,0586 | +14,68% | 5 012 |
22-04-24 | 0,0511 | -6,07% | 2 320 |
uitgestelde koers OTC Markets, 26 april 2024 om 20:10 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+49,73% | 678K | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |